Crossmark

Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

Crossref DOI link: https://doi.org/10.1186/s12864-015-1935-0

Published Online: 2015-10-06

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aramburu, Ander

Zudaire, Isabel

Pajares, María J.

Agorreta, Jackeline

Orta, Alberto

Lozano, María D.

Gúrpide, Alfonso

Gómez-Román, Javier

Martinez-Climent, Jose A.

Jassem, Jacek

Skrzypski, Marcin

Suraokar, Milind

Behrens, Carmen

Wistuba, Ignacio I.

Pio, Ruben

Rubio, Angel

Montuenga, Luis M.
Funding

Funding for this research was provided by:

European Union (HEALTH-F2-2010-258677)

Spanish Ministry of Economy and Innovation (ISCIII-RTICC PI10/00166, PI13/00806; RD12/0036/0040; RD12/0036/0062; RD12/0036/0063)

Government of Navarra, Department of Health (21/2009)

AECC Scientific Foundation (GCB14-2170)
License Information

Text and Data Mining valid from 2015-10-06
More Information

Article History

Received: 20 April 2015

Accepted: 21 September 2015

First Online: 6 October 2015